|
⚲
|
| Keyboard |
| Yachmetz Philip K
✚
|
|
|---|---|
| CIK # | 0001250318 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001250318] | |
| 4 | [0001250318] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Yachmetz Philip K | |
| IGI Laboratories Inc | |
| Savient Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
IGI Laboratories Inc TLGT
Restricted Stock Units · derivative
|
2021-07-16 | Option exercise | 7,835 | $0.00 | |
|
IGI Laboratories Inc TLGT
Common Stock
|
2021-07-16 | Tax withheld | 2,656 | $0.47 | 1,248 |
|
IGI Laboratories Inc TLGT
Common Stock
|
2021-07-16 | Option exercise | 7,835 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2021-03-11 | Grant | 424,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Restricted Stock Units · derivative
|
2021-03-11 | Grant | 344,000 | $0.00 | |
|
IGI Laboratories Inc TLGT
Restricted Stock Units · derivative
|
2020-07-16 | Grant | 23,505 | $0.00 | |
|
IGI Laboratories Inc TLGT
Stock Option · derivative
|
2020-07-16 | Grant | 36,325 | $0.00 | |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 10,000 | $0.09 | 900 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 50,000 | $0.10 | 5,000 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 53,411 | $0.10 | 5,341 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 40,000 | $0.10 | 4,000 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 20,000 | $0.09 | 1,800 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 19,745 | $0.10 | 1,974 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock
|
2013-10-15 | Sell | 20,000 | $0.10 | 2,000 |
|
Savient Pharmaceuticals Inc SVNT
Option to Purchase Common Stock · derivative
|
2013-03-05 | Grant | 78,000 | $0.00 | |
|
Savient Pharmaceuticals Inc SVNT
Option to Purchase Common Stock · derivative
|
2013-03-05 | Grant | 110,000 | $0.00 | |
|
Savient Pharmaceuticals Inc SVNT
Common Stock $.01 par value per share
|
2013-02-04 | Sell | 3,203 | $1.02 | 3,267 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock $.01 par value per share
|
2013-02-04 | Sell | 27,297 | $1.01 | 27,570 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock $.01 par value per share
|
2013-01-14 | Sell | 1,283 | $1.14 | 1,463 |
|
Savient Pharmaceuticals Inc SVNT
Common Stock, $.01 par value
|
2012-02-27 | Grant | 100,000 | $2.10 | 210,000 |
| showing 20 of 23 most recent transactions | |||||